Ken Griffin Accuray Inc Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.41 - $2.49 $11,703 - $20,667	8,300 New	8,300 $14,000
Q1 2024 May 15, 2024	SELL	$2.37 - $2.94 $78,684 - $97,608	-33,200 Reduced 77.57%	9,600 $23,000
Q4 2023 Feb 14, 2024	BUY	$2.44 - $3.08 $53,680 - $67,760	22,000 Added 105.77%	42,800 $121,000
Q3 2023 Nov 14, 2023	SELL	$2.63 - $4.26 $1,315 - $2,130	-500 Reduced 2.35%	20,800 $56,000
Q2 2023 Aug 14, 2023	SELL	$2.7 - $3.97 $21,060 - $30,966	-7,800 Reduced 26.8%	21,300 $82,000
Q1 2023 May 15, 2023	BUY	$2.06 - $3.18 $52,118 - $80,454	25,300 Added 665.79%	29,100 $86,000
Q4 2022 Feb 14, 2023	BUY	$1.88 - $2.4 $7,144 - $9,120	3,800 New	3,800 $7,000

134

55.9M

26.2K

12.8K

Ticker ARAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 93,579,696
Market Cap $159M
Description
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.